STK1p Based on the Serum Thymidine Kinase 1 as a Tumour Proliferation Marker Detected for Risk Assessment of Pre-carcinoma to Carcinoma Colorectal Progression: A Meta-Analysis
The goal of this study was to see if serum thymidine kinase 1 concentration (STK1p) could be used to predict the likelihood of progression from colorectal adenoma polyp/dysplasia to colorectal carcinoma using the TK1-IgY-pAb (CRC). The current meta-analysis looked at 25 papers that included patients with CRC (n=2,251), patients...
Read More
Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People
STK1p, a serological thymidine kinase 1 (STK1p) proliferation marker, is a reliable prognostic, monitoring, and relapse marker. The application of STK1p in health screening for early diagnosis of pre-malignant and malignant disorders was examined in this study. The research was based on 35,365 people who took part in four...
Read More